Picture of Black Diamond Therapeutics logo

BDTX Black Diamond Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Black Diamond Therapeutics Reports Pipeline Prioritization, Workforce Realignment

April 25 (Reuters) - Black Diamond Therapeutics Inc
 BDTX.O :
    * BLACK DIAMOND THERAPEUTICS ANNOUNCES PIPELINE
PRIORITIZATION AND
WORKFORCE REALIGNMENT
    * BLACK DIAMOND THERAPEUTICS INC - COMPANY TO DISCONTINUE
DEVELOPMENT OF BDTX-189 AND REDUCE WORKFORCE TO EXTEND ITS CASH
RUNWAY INTO 3Q 2024
    * BLACK DIAMOND THERAPEUTICS INC - STRATEGIC AREAS OF FOCUS
ON
DEVELOPMENT OF BDTX-1535 AND BDTX-4933
    * BLACK DIAMOND THERAPEUTICS INC - DECIDED TO DISCONTINUE
DEVELOPMENT OF PROGRAM DUE TO RAPID EVOLUTION OF TREATMENT
LANDSCAPE IN NON-SMALL CELL LUNG CANCER

Source text for Eikon:  ID:nGNX54T9rh 
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Black Diamond Therapeutics

See all news